The effects of FasL on inflammation and tumor survival are dependent on its expression levels.

Wada, A; Tada, Y; Kawamura, K; Takiguchi, Y; Tatsumi, K; Kuriyama, T; Takenouchi, T; O-Wang, J; Tagawa, M

Wada, A; Tada, Y; Kawamura, K; Takiguchi, Y; Tatsumi, K; Kuriyama, T; Takenouchi, T; O-Wang, J; Tagawa, M.

Affiliation

Wada A; Division of Pathology, Chiba Cancer Center Research Institute, Chiba, Japan.

Cancer Gene Ther ; 14(3): 262-7, 2007 Mar.

Article in En | MEDLINE | ID: mdl-17053813

Subject(s)

Carcinoma, Lewis Lung/pathology; Fas Ligand Protein/physiology; Melanoma, Experimental/pathology; T-Lymphocytes/immunology; Animals; Apoptosis; CD40 Ligand/pharmacology; Carcinoma, Lewis Lung/immunology; Coculture Techniques; Cytotoxicity, Immunologic/genetics; Female; Flow Cytometry; Humans; In Situ Nick-End Labeling; Inflammation/pathology; Melanoma, Experimental/immunology; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neutrophils/immunology; Spleen/cytology; Spleen/drug effects; Transfection

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / T-Lymphocytes / Carcinoma, Lewis Lung / Fas Ligand Protein Limits: Animals / Female / Humans Language: En Journal: Cancer Gene Ther Journal subject: GENETICA MEDICA / NEOPLASIAS / TERAPEUTICA Year: 2007 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links